Clin Mol Hepatol.
2024 Apr;30(2):276-278. 10.3350/cmh.2024.0220.
Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan
- 2School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan
- 3Department of Public Health, National Cheng Kung University, College of Medicine, Tainan, Taiwan
- 4Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
- KMID: 2554436
- DOI: http://doi.org/10.3350/cmh.2024.0220
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen
- Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
- Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
- Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
- Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation
